| # | Drug | Count |
|---|---|---|
| 0 | FULVESTRANT | 35 |
| 1 | LEVONORGESTREL | 27 |
| 2 | DENOSUMAB | 24 |
| 3 | ACETAMINOPHEN | 23 |
| 4 | CAPECITABINE | 23 |
| 5 | PALBOCICLIB | 22 |
| 6 | ADALIMUMAB | 21 |
| 7 | ERGOCALCIFEROL | 21 |
| 8 | GABAPENTIN | 19 |
| 9 | IBUPROFEN | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEVACIZUMAB-BVZR | 3 | 0.0043 |
| 1 | PROPAFENONE | 8 | 0.0019 |
| 2 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 7 | 0.0015 |
| 3 | FULVESTRANT | 35 | 0.0010 |
| 4 | GOSERELIN | 11 | 0.0008 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 6 | ERGOCALCIFEROL | 21 | 0.0007 |
| 7 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 8 | MEPERIDINE HYDROCHLORIDE | 5 | 0.0005 |
| 9 | METHYLPREDNISOLONE ACETATE | 4 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 46 |
| 1 | Estrogen Receptor Antagonist [EPC] | 35 |
| 2 | Kinase Inhibitor [EPC] | 35 |
| 3 | Progestin [EPC] | 34 |
| 4 | Benzodiazepine [EPC] | 27 |
| 5 | Estrogen [EPC] | 27 |
| 6 | Progestin-containing Intrauterine System [EPC] | 27 |
| 7 | Corticosteroid [EPC] | 26 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 26 |
| 9 | RANK Ligand Inhibitor [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyrethroid [EPC] | 2 | 0.0011 |
| 1 | Estrogen Receptor Antagonist [EPC] | 35 | 0.0009 |
| 2 | Provitamin D2 Compound [EPC] | 21 | 0.0007 |
| 3 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Non-narcotic Antitussive [EPC] | 4 | 0.0002 |
| 5 | Cephalosporin Antibacterial [EPC] | 2 | 0.0002 |
| 6 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 7 | Quinolone Antimicrobial [EPC] | 2 | 0.0002 |
| 8 | Bismuth [EPC] | 1 | 0.0002 |
| 9 | Barbiturate [EPC] | 2 | 0.0002 |